CVS Health (CVS) Stock Buyback History
TTM buyback yield N/A.
CVS
TTM buyback yield
N/A
Shareholder yield (TTM)
N/A
5Y share count change
-3.3%
TTM buyback spend
N/A
SBC coverage (TTM)
0.00x
YoY change in spend
-100.0%
5Y CAGR of spend
N/A
Peak year (2007)
$5.37B
Cumulative spend
$47.73B
TTM metrics calculated from the four most recent reported quarters, ending (reported ).
Key takeaways
- Diluted share count is down 3.3% over the last ~5 fiscal years — buybacks are net-shrinking the share base.
- TTM repurchases used about 0% of free cash flow remaining after dividends.
Buyback context per fiscal year
Annual repurchases alongside stock-based compensation, diluted share count and the year-over-year change — useful for SBC-coverage and dilution-offset reading at a glance.
| Year | Buybacks | SBC | Net | Shares (dil.) | YoY shares | Buyback yield |
|---|---|---|---|---|---|---|
| 2025 | $0.00 | $535.00M | −$535.00M | 1.27B | 0.7% | — |
| 2024 | $3.02B | $540.00M | $2.48B | 1.26B | -2.2% | 5.35% |
| 2023 | $2.01B | $588.00M | $1.42B | 1.29B | -2.5% | 1.98% |
| 2022 | $3.50B | $447.00M | $3.05B | 1.32B | -0.5% | 2.87% |
| 2021 | $0.00 | $484.00M | −$484.00M | 1.33B | 1.1% | — |
| 2020 | $0.00 | $400.00M | −$400.00M | 1.31B | 0.7% | — |
| 2019 | $0.00 | $453.00M | −$453.00M | 1.30B | 25.0% | — |
| 2018 | $0.00 | $280.00M | −$280.00M | 1.04B | 2.0% | — |
| 2017 | $4.36B | $234.00M | $4.13B | 1.02B | -5.1% | 5.93% |
| 2016 | $4.46B | $222.00M | $4.24B | 1.08B | -4.2% | 5.31% |
| 2015 | $5.00B | $230.00M | $4.77B | 1.13B | -3.7% | 4.62% |
| 2014 | $4.00B | $165.00M | $3.84B | 1.17B | -4.6% | 3.68% |
| 2013 | $3.98B | $141.00M | $3.83B | 1.23B | -4.2% | 4.66% |
| 2012 | $4.33B | $132.00M | $4.20B | 1.28B | -5.0% | 7.22% |
| 2011 | $3.00B | $135.00M | $2.87B | 1.35B | -2.2% | 5.67% |
| 2010 | $1.50B | $150.00M | $1.35B | 1.38B | -5.0% | 3.17% |
| 2009 | $2.48B | $165.00M | $2.31B | 1.45B | -1.3% | 5.55% |
| 2008 | $23.00M | $92.00M | −$69.00M | 1.47B | 7.1% | 0.06% |
| 2007 | $5.37B | $0.00 | $5.37B | 1.37B | 60.8% | 9.38% |
| 2006 | $0.00 | $0.00 | $0.00 | 0.85B | 1.4% | — |
| 2005 | $0.00 | $0.00 | $0.00 | 0.84B | 2.3% | — |
| 2004 | $0.00 | $0.00 | $0.00 | 0.82B | 1.7% | — |
| 2003 | $0.00 | $0.00 | $0.00 | 0.81B | -0.3% | — |
| 2002 | $0.00 | $0.00 | $0.00 | 0.81B | 1.7% | — |
| 2001 | $129.00M | $0.00 | $129.00M | 0.80B | -0.3% | 1.13% |
| 2000 | $163.20M | $0.00 | $163.20M | 0.80B | -2.3% | — |
| 1999 | $0.00 | $0.00 | $0.00 | 0.82B | 0.9% | — |
| 1998 | $0.00 | $0.00 | $0.00 | 0.81B | 2.5% | — |
| 1997 | $0.00 | $0.00 | $0.00 | 0.79B | 85.4% | — |
| 1996 | $0.00 | $0.00 | $0.00 | 0.43B | — | — |
| 1995 | $39.10M | $0.00 | $39.10M | — | — | — |
| 1994 | $0.00 | $0.00 | $0.00 | — | — | — |
| 1993 | $0.00 | $0.00 | $0.00 | — | — | — |
| 1992 | $0.00 | $0.00 | $0.00 | — | — | — |
| 1991 | $0.00 | $0.00 | $0.00 | — | — | — |
| 1990 | $3.80M | $0.00 | $3.80M | — | — | — |
| 1989 | $357.50M | $0.00 | $357.50M | — | — | — |
Cash buyback spend (USD) — annual & quarterly history
Trailing-twelve-month and per-period cash repurchases for CVS Health (CVS) from the consolidated cash flow statement (line: common stock repurchased), in USD as filed.
Cash buyback spend over time for CVS Health (CVS)
Per-period cash repurchases
Cash buyback spend annual + quarterly history for CVS Health (CVS)
| Fiscal year | Period ended | Reported | Buyback Spend | YoY | YoY change |
|---|---|---|---|---|---|
| 2025 | $0 | -100.0% | -$3.02B | ||
| 2024 | $3.02B | +50.2% | +$1.01B | ||
| 2023 | $2.01B | -42.5% | -$1.49B | ||
| 2022 | $3.50B | — | +$3.50B | ||
| 2021 | $0 | — | $0 | ||
| 2020 | $0 | — | $0 | ||
| 2019 | $0 | — | $0 | ||
| 2018 | $0 | -100.0% | -$4.36B | ||
| 2017 | $4.36B | -2.2% | -$100.00M | ||
| 2016 | $4.46B | -10.8% | -$540.00M | ||
| 2015 | $5.00B | +25.0% | +$1.00B | ||
| 2014 | $4.00B | +0.6% | +$25.00M | ||
| 2013 | $3.98B | -8.2% | -$354.00M | ||
| 2012 | $4.33B | +44.3% | +$1.33B | ||
| 2011 | $3.00B | +100.1% | +$1.50B | ||
| 2010 | $1.50B | -39.4% | -$977.00M | ||
| 2009 | $2.48B | +10669.6% | +$2.45B | ||
| 2008 | $23.00M | -99.6% | -$5.35B | ||
| 2007 | $5.37B | — | +$5.37B | ||
| 2006 | $0 | — | $0 | ||
| 2005 | $0 | — | $0 | ||
| 2004 | $0 | — | $0 | ||
| 2003 | $0 | — | $0 | ||
| 2002 | $0 | -100.0% | -$129.00M | ||
| 2001 | $129.00M | -21.0% | -$34.20M | ||
| 2000 | $163.20M | — | +$163.20M | ||
| 1999 | $0 | — | $0 | ||
| 1998 | $0 | — | $0 | ||
| 1997 | $0 | — | $0 | ||
| 1996 | $0 | -100.0% | -$39.10M | ||
| 1995 | $39.10M | — | +$39.10M | ||
| 1994 | $0 | — | $0 | ||
| 1993 | $0 | — | $0 | ||
| 1992 | $0 | — | $0 | ||
| 1991 | $0 | -100.0% | -$3.80M | ||
| 1990 | $3.80M | -98.9% | -$353.70M | ||
| 1989 | $357.50M | — | — |
As of the 2025 fiscal year, CVS Health (CVS) reported buyback spend of $0 – plunged 100.0% year-over-year.
Through 2015–2025 (10 years), CVS Health buyback spend delivered a -100.0% annualised rate; with a net decline across the window.
CVS Health buyback spend peaked at $5.37B in 2007; the latest annual figure is $0 in 2025 (100.0% below peak).
The highest annual buyback spend of $5.37B was reported in 2007. The lowest in the available history was $0 in 1991.
Among 8 Healthcare peers, CVS Health (CVS) ranks 8th; the peer median for buyback spend is $2.75B.
CVS Health Buyback Spend 2025: $0
CVS Health buyback spend in 2025 was $0, plunged 100.0% below 2024.
CVS Health Buyback Spend 2024: $3.02B
CVS Health buyback spend in 2024 was $3.02B, surged 50.2% from 2023.
CVS Health Buyback Spend 2023: $2.01B
CVS Health buyback spend in 2023 was $2.01B, plunged 42.5% below 2022.
CVS Health Buyback Spend 2022: $3.50B
CVS Health buyback spend in 2022 was $3.50B.
CVS Health Buyback Spend 2021: $0
CVS Health buyback spend in 2021 was $0.
See more financial history for CVS Health (CVS).
Sector peers by buyback spend
Companies in the same sector as CVS Health, ranked by their latest buyback spend.
| Company | Buyback Spend | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $5.95B | Healthcare |
| UnitedHealth Group (UNH) | $5.54B | Healthcare |
| Merck & Co. (MRK) | $5.08B | Healthcare |
| Eli Lilly (LLY) | $4.11B | Healthcare |
| Novo Nordisk (NVO) | $1.39B | Healthcare |
| AbbVie (ABBV) | $980.00M | Healthcare |
| AstraZeneca (AZN) | $719.66M | Healthcare |
| Amgen (AMGN) | $0 | Healthcare |
Share count history
Diluted weighted-average shares drive the EPS denominator and per-share capital-return maths. A falling diluted share count means buybacks are outpacing dilution from stock-based compensation and option exercises.
Diluted vs basic shares (annual)
Year-over-year change in diluted shares
Green is fewer shares vs the prior fiscal year (net repurchase); red is growth (dilution). The earliest year shown has no prior year to compare.
Dividend & buyback yield over time
Stacked annual yields — buyback yield (TTM cash repurchases ÷ market cap) plus dividend yield from the same fiscal-year-end key-metrics period — show how total cash return per dollar of equity has evolved.
Buybacks vs stock-based compensation
Annual cash repurchases set against stock-based compensation. Coverage above 1× means buybacks fully offset the equity dilution from SBC. TTM coverage: 0.00×.
Capital allocation mix
How CVS Health splits cash returned to shareholders between dividends and buybacks, plus the headroom on free cash flow that's still available for additional repurchases.
Buybacks vs dividends (share of cash returned)
Buyback capacity (TTM)
Free cash flow minus dividends paid versus actual TTM repurchases — the headroom bar shows how much of post-dividend FCF is still being deployed elsewhere.
Headroom $3.99B (TTM FCF − TTM dividends, clamped at zero).
Data & methodology
Where do buyback, dividend and compensation figures come from?
Cash buyback spend (common stock repurchased), dividends paid and stock-based compensation come from CVS Health's consolidated cash flow statements — quarterly 10-Q and annual 10-K SEC filings, in USD as reported.
How are diluted shares and yields calculated?
Diluted weighted-average share counts come from the income statement (EPS denominator). Trailing twelve-month (TTM) aggregates sum the four most recent reported quarters. Buyback and dividend yields divide TTM cash flows by market capitalisation at the latest quarter-end.
How is buyback capacity defined?
Capacity compares TTM repurchases to free cash flow after dividends: operating cash flow minus capital expenditure, minus dividends paid, versus actual buybacks over the same trailing window.
Is this investment advice?
No. Figures are for informational and educational use only. Past buybacks and dividends do not predict future returns.
Frequently asked questions
Does CVS Health buy back its own stock?
Yes, CVS Health (CVS) has repurchased shares in recent periods. See the history table and charts on this page for amounts and trends.
Is CVS Health diluting shareholders?
Compare stock-based compensation (SBC) to buybacks in the chart above. Net effect varies by year; see annual buyback vs SBC bars and the history table.
How has CVS Health's share count changed?
Diluted weighted average shares changed by about -3.3% over roughly five fiscal years (annual income statement data).
What is CVS Health's buyback spend?
Latest reported buyback spend for CVS Health (CVS) is $0 (period ending March 31, 2026).
How has CVS Health buyback spend changed year-over-year?
CVS Health (CVS) buyback spend changed -100.0% year-over-year on the latest annual filing.
What is the long-term growth rate of CVS Health buyback spend?
CVS Health (CVS) buyback spend compound annual growth rate is -100.0% over the most recent 10 years available.
When did CVS Health buyback spend hit its highest annual value?
CVS Health buyback spend reached its highest annual value of $5.37B in 2007.
What was CVS Health buyback spend in 2024?
CVS Health (CVS) buyback spend in 2024 was $3.02B.
What was CVS Health buyback spend in 2025?
CVS Health (CVS) buyback spend in 2025 was $0.
Explore more
CVS Overview
Company profile, financial tools, and key metrics
CVS Revenue Counter
Earns $12,935 every second. See per minute, hour, and day.
CVS Earnings Counter
Earns $92.97 per second net profit. See per minute, hour, and day.
CVS Economic Scale
Exceeds Hong Kong SAR, China's GDP. Compare with world economies.
CVS What If Invested
What if you had invested $1,000? See historical returns from any date.
CVS How It Makes Money
Discover visual breakdown of $407.90B in revenue — where it comes from and where it goes.
CVS Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
CVS Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
CVS Daily Price Character
Steady · 50.0% historical win rate (green days). Streaks & record days.
CVS Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
CVS Dividend Profile
Yield: 2.85%. Safety: 4/8. See full history.
CVS Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
CVS Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.
CVS Dividend Capture
Historical pre-ex touch stats, gap distribution, after-tax calculator, and a backtest simulator (limit-order vs MOC exit).
CVS Financials
Revenue, EPS, EBITDA, market cap, debt and balance sheet history with annual and quarterly data.